The role of miR-214 in cardiovascular diseases

• Published in: European journal of pharmacology Vol. 816; pp. 138 - 145
• Main Authors: Zhao, Yanfang, Ponnusamy, Murugavel, Zhang, Lei, Zhang, Yuan, Liu, Cuiyun, Yu, Wanpeng, Wang, Kun, Li, Peifeng
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 05.12.2017
• Subjects: Angiogenesis; Animals; Cardiac hypertrophy; Cardiovascular Diseases - drug therapy; Cardiovascular Diseases - genetics; Cardiovascular Diseases - physiopathology; Heart failure; Humans; Ischaemic heart diseases; MicroRNAs - genetics; MiR-214; Molecular Targeted Therapy; Neovascularization, Pathologic; Pulmonary arterial hypertension; Heart failure; Cardiac hypertrophy; Angiogenesis; Ischaemic heart diseases; Pulmonary arterial hypertension; MiR-214

Cardiovascular disease (CVD) is the leading cause of death throughout the world. The increase in new patients every year leads to a demand for the identification of valid and novel prognostic and diagnostic biomarkers for the prevention and treatment of cardiovascular diseases. MicroRNAs (miRNAs) ar...